Laffer Tengler Investments Merck & Co., Inc. Transaction History

Laffer Tengler Investments

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $2,831 - $3,298	-25 Reduced 2.3%	1,064 $140 Million
Q4 2023 Feb 08, 2024	BUY	$100.18 - $109.02 $8,916 - $9,702	89 Added 8.9%	1,089 $119 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $108,610 - $118,380	1,000 New	1,000 $115 Million
Q1 2023 May 09, 2023	BUY	$102.94 - $114.86 $32,529 - $36,295	316 Added 31.6%	1,316 $140 Million
Q3 2021 Nov 16, 2021	BUY	$71.68 - $78.83 $71,680 - $78,830	1,000 New	1,000 $75.1 Million
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $70,310 - $77,770	-1,000 Closed	0 $0
Q4 2020 Jun 11, 2021	BUY	$71.77 - $79.65 $71,770 - $79,650	1,000 New	1,000 $80.6 Million
Q4 2020 Feb 19, 2021	SELL	$71.77 - $79.65 $71,770 - $79,650	-1,000 Closed	0 $0
Q2 2020 Jun 11, 2021	BUY	$70.42 - $80.13 $70,420 - $80,130	1,000 New	1,000 $77.3 Million
Q2 2019 Aug 15, 2019	SELL	$69.84 - $81.59 $4.82 Million - $5.64 Million	-69,085 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$50.96 - $59.23 $3.52 Million - $4.09 Million	69,085 New	69,085 $3.76 Billion

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $257B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Laffer Tengler Investments, based on Form 13F filings with the SEC.

Stay updated on Laffer Tengler Investments with notifications on news.